Clinical Trials
4 trialsNCT05370235 2023-09-21
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V
Clinuvel Pharmaceuticals Limited
Phase 2 Unknown
NCT05159752 2023-06-18
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)
Clinuvel Pharmaceuticals Limited
Phase 2 Unknown
NCT03662828 2019-05-14
KAPOSI-1
Direction Centrale du Service de Santé des Armées
Unknown
NCT01123694 2010-05-14
Xeroderma Pigmentosum Patient Experiences
Henry Ford Health System
Unknown